A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

7.9K views

⸱

DOI:

10.3791/56689

⸱

December 26th, 2017

 , 

In This Article

Summary

Antibody-based drugs have revolutionized treatment for inflammatory diseases. In addition to having direct effects on specific targets, antibodies can activate macrophages to become anti-inflammatory. This protocol describes how anti-inflammatory macrophage activation can be assessed in vitro, using mouse bone marrow macrophages, and in vivo, using peritoneal macrophages.

Abstract

Macrophages are phagocytic innate immune cells, which initiate immune responses to pathogens and contribute to healing and tissue restitution. Macrophages are equally important in turning off inflammatory responses. We have shown that macrophages stimulated with intravenous immunoglobulin (IVIg) can produce high amounts of the anti-inflammatory cytokine, interleukin 10 (IL-10), and low levels of pro-inflammatory cytokines in response to bacterial lipopolysaccharides (LPS). IVIg is a polyvalent antibody, primarily immunoglobulin Gs (IgGs), pooled from the plasma of more than 1,000 blood donors. It is used to supplement antibodies in patients with immune deficiencies or to suppress immune responses in patients with autoimmune or inflammatory conditions. Infliximab, a therapeutic anti-tumor necrosis factor alpha (TNFα) antibody, has also been shown to activate macrophages to produce IL-10 in response to inflammatory stimuli. IVIg and other antibody-based biologics can be tested to determine their effects on macrophage activation. This paper describes methods for derivation, stimulation, and assessment of murine bone marrow macrophages activated by antibodies in vitro and murine peritoneal macrophages activated with antibodies in vivo. Finally, we demonstrate the use of western blotting to determine the contribution of specific cell signaling pathways to anti-inflammatory macrophage activity. These protocols can be used with genetically modified mice, to determine the effect of a specific protein(s) on anti-inflammatory macrophage activation. These techniques can also be used to assess whether specific biologics may act by changing macrophages to an IL-10-producing anti-inflammatory activation state that reduces inflammatory responses in vivo. This can provide information on the role of macrophage activation in the efficacy of biologics during disease models in mice, and provide insight into a potential new mechanism of action in people. Conversely, this may caution against the use of specific antibody-based biologics to treat infectious disease, particularly if macrophages play an important role in host defense against that infection.

Introduction

Macrophages are innate immune cells, which play multiple roles in the immune response to infection or injury. Macrophages are responsible for initiating an immune response to infection or tissue damage, stopping the inflammatory response, and promoting the healing response1. Examples of the three best studied macrophage activation states are: 1) macrophages treated with interferon gamma (IFNγ) and bacterial lipopolysaccharide (LPS), designated M(IFNγ + LPS), which contribute to the inflammatory response; 2) macrophages stimulated with interleukin 4 (IL-4), M(IL-4), which are associated with the healing response; 3) macrophages stimula....

Access restricted. Please log in or start a trial to view this content.

Protocol

All methods described here have been approved by the Institutional Animal Care and Use Committee (IACUC) of the University of British Columbia.

1. Bone Marrow Macrophage Derivation and Activation with Antibodies

  1. Perform euthanasia using CO2 asphyxiation.
    1. Place mouse in induction chamber. Euthanize mouse with 5% isoflurane anesthesia, for 60 - 90 s, until immobile and breathing is deep and slow.
    2. Turn off isoflurane anesthesia and administer 6 - 8 L/min of CO2 until mouse has stopped breathing. Leave mouse with CO2 on for at least another 5 min. Verify that there is no longer....

Access restricted. Please log in or start a trial to view this content.

Results

Murine bone marrow derived macrophages can be cultured from hematopoietic cell precursors in bone marrow aspirates. Bone marrow aspirates pooled from femurs and tibias of one C57BL/6 mouse typically yield 107 bone marrow derived macrophages, making them a convenient source of macrophages for experiments. BMDMs can be used to test antibody based drug responses when challenged with an inflammatory stimulus in vitro. Figure 1 shows that IVIg .......

Access restricted. Please log in or start a trial to view this content.

Discussion

Macrophage activation states play an important role in both tissue homeostasis and disease22. Macrophages can have distinct as well as overlapping activation states, depending on cues in their microenvironment3. They have distinct roles in all stages of the inflammatory response: defense against pathogens, wound healing and tissue restitution, and also have a distinct anti-inflammatory activation state that is important for turning off the inflammatory response

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have no conflicts of interest to disclose.

Acknowledgements

L.K. is the recipient of the University of British Columbia 4-year fellowship (4YF) graduate studentship award. L.M.S. is the recipient of a Canadian Association of Gastroenterology/ Crohn's and Colitis Canada/ CIHR New Investigator Salary Award and is a Biomedical Scholar of the Michael Smith Foundation for Health Research. This work was supported by a Project Grant from Canadian Blood Services, in collaboration with the Canadian Institutes of Health Research (grant # CIHR2016-LS).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Iscove’s modified Dulbecco’s medium (IMDM)Life technologies12440053
Fetal Bovine Serum (FBS)Life technologies12483-020
Recombinant murine macrophage colony stimulating factor (MCSF)Stemcell technologies78059
Penicillin-streptomycinLife technologies15140148
Monothioglycerol (MTG)Sigma88640
1X red blood cell lysis buffereBioscience
Cell dissociation bufferLife technologies13150016Enzyme-Free, Hanks's-based, EDTA
Lipopolysaccharide (LPS)Sigma aldrichL 4516From E. coli 0127:B8
IVIg (Gammunex)GrifolsReceived from BC Children's Hospital, Transfusion Medicine
IVIg (Gammagard liquid)Baxter Healthcare CorporationReceived from BC Children's Hospital, Transfusion Medicine
IVIg (Octagam)OctapharmaReceived from BC Children's Hospital, Transfusion Medicine
Phosphate buffered saline (PBS) (sterile), pH 7.4Life technologies10010023
mouse IL-10 ELISABD biosciences555252
mouse IL-12/23p40 ELISABD biosciences555165
anti-Erk1/2 antibodyCell signalling technology9101
anti-pp38 antibodyCell signalling technology9211
anti-GAPDH antibodyFitzgerald industries10R-G109A
26 g needleBD biosciences305110
1 mL syringeBD biosciences309659
10 mL syringeBD biosciences309604
15 mL conical tubeBD biosciences352096
50 mL conical tubeBD biosciences352070
microcentrifuge tube (1.7 mL)DiamedSPE155-N
75 cm2 tissue culture treated flaskBD biosciences353136
Cell scraperBD biosciences353085
ForceptsVWR82027-386fine tip, dissecting 
ScissorsVWR82027-582Delicate, 4 1/2"
Brightfield microscopeMoticAE31Inverted phase contrast
Scale Mettler PE 3000

References

  1. Murray, P. J., Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 11 (11), 723-737 (2011).
  2. Martinez, F. O., Gordon, S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6, 13(201....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Bone Marrow MacrophagesPeritoneal MacrophagesIntravenous ImmunoglobulinIL-10 ProductionWestern BlottingCell StimulationCytokine AnalysisMouse Models